Washington
Fee-For-Service Medicaid Coverage of Screening
Yes
Highlighted Disparity
Asian Americans or Pacific Islanders in Washington are least likely to be diagnosed early.
Lung Cancer Rates
New Cases:
- The rate of new lung cancer cases is 53 and significantly lower than the national rate of 58.
- Washington ranks 13th among all states, placing it in the average tier.
- Over the last five years, the rate of new cases improved by 15%.
5-Year Survival Rate:
- The percent of people alive five years after being diagnosed with lung cancer (the survival rate) in Washington is 26%, which is significantly higher than the national rate of 24%.
- It ranks 11th among the 45 states with survival data, placing it in the above average tier.
- The change in the survival rate over the last five years is not available for Washington.
Early Diagnosis:
- 24% of cases are caught at an early stage, which is not significantly different than the national rate of 24%.
- It ranks 26th among the 49 states with data on diagnosis at an early stage, placing it in the average tier.
- Over the last five years, the early diagnosis rate in Washington improved by 36%.
Lung Cancer Treatment
Surgical Treatment:
- Washington ranked 21st (out of the 49 states with available data) with 20% of cases undergoing surgery as part of the first course of treatment.
- This is not significantly different than the national rate of 20.7% and puts Washington in the average tier.
- Over the last five years, the percent of cases undergoing surgery in Washington improved by 12%.
Lack of Treatment:
- Washington ranked 37th (out of the 49 states with available data) with 24% of cases not receiving any treatment.
- This is significantly higher than the national rate of 21% and puts Washington in the below average tier.
- Over the last five years, the percent of cases receiving no treatment in Washington improved by 35%.
Screening
Screening for High Risk:
- In Washington, 7% of those at high risk were screened, which was significantly higher than the national rate of 6%.
- It ranks 22nd among all states, placing it in the average tier.
Medicaid Coverage:
- Washington was one of the 40 states whose Medicaid fee-for-service programs covered lung cancer screening as of September 2021.
- While their program used recommended guidelines for determining eligibility and did not require cost sharing, it did require prior authorization.
Prevention
Tobacco Use:
- The smoking rate in Washington is 13% and significantly lower than the national rate of 15%.
- It ranks 6th among all states, placing it in the above average tier.
Radon:
- In Washington, 11% of radon tests results were at or above the action level recommended by EPA.
- It ranks 10th among all states, placing it in the above average tier.
Racial & Ethnic Disparities
Black Americans:
- The rate of new lung cancer cases is 55 per 100,000 population among Black Americans in Washington, not significantly different than the rate of 60 among Black Americans nationally, and not significantly different than the rate of 55 among whites in Washington.
- The five-year survival rate is 26% among Black Americans in Washington, not significantly different than the rate of 21% among Black Americans nationally, and not significantly different than the rate of 25% among whites in Washington.
- 24% of lung cancer cases are diagnosed at an early stage among Black Americans in Washington, not significantly different than the rate of 21% among Black Americans nationally, and not significantly different than the rate of 25% among whites in Washington.
- 19% of Black Americans with lung cancer in Washington underwent surgery, not significantly different than the rate of 17% among Black Americans nationally, and not significantly different than the rate of 20% among whites in Washington.
- 25% of Black Americans with lung cancer in Washington did not receive any treatment, not significantly different than the rate of 23% among Black Americans nationally, and not significantly different than the rate of 24% among whites in Washington.
Latino Americans:
- The rate of new lung cancer cases is 35 per 100,000 population among Latinos in Washington, significantly higher than the rate of 29 among Latinos nationally, and significantly lower than the rate of 55 among whites in Washington.
- State-level survival rates are not available for Latino Americans at this time. Nationally, the five-year survival rate among Latino Americans is 19%, 13% lower than among white Americans.
- 22% of lung cancer cases are diagnosed at an early stage among Latinos in Washington, not significantly different than the rate of 22% among Latinos nationally, and not significantly different than the rate of 25% among whites in Washington.
- 23% of Latinos with lung cancer in Washington underwent surgery, significantly higher than the rate of 21% among Latinos nationally, and significantly higher than the rate of 20% among whites in Washington.
- 22% of Latinos with lung cancer in Washington did not receive any treatment, significantly lower than the rate of 26% among Latinos nationally, and not significantly different than the rate of 24% among whites in Washington.
Asian Americans or Pacific Islanders:
- The rate of new lung cancer cases is 37 per 100,000 population among Asian Americans or Pacific Islanders in Washington, significantly higher than the rate of 34 among Asian Americans or Pacific Islanders nationally, and significantly lower than the rate of 55 among whites in Washington.
- State-level survival rates are not available for Asian Americans or Pacific Islanders at this time. Nationally, the five-year survival rate among Asian Americans or Pacific Islanders is 23%, 8% higher than among white Americans.
- 21% of lung cancer cases are diagnosed at an early stage among Asian Americans or Pacific Islanders in Washington, not significantly different than the rate of 21% among Asian Americans or Pacific Islanders nationally, and significantly lower than the rate of 25% among whites in Washington.
- 21% of Asian Americans or Pacific Islanders with lung cancer in Washington underwent surgery, significantly lower than the rate of 24% among Asian Americans or Pacific Islanders nationally, and not significantly different than the rate of 20% among whites in Washington.
- 23% of Asian Americans or Pacific Islanders with lung cancer in Washington did not receive any treatment, not significantly different than the rate of 22% among Asian Americans or Pacific Islanders nationally, and not significantly different than the rate of 24% among whites in Washington.
Indigenous Peoples:
- The rate of new lung cancer cases is 63 per 100,000 population among Indigenous Peoples (American Indians/Alaska Natives) in Washington, significantly higher than the rate of 41 among Indigenous Peoples nationally, and not significantly different than the rate of 55 among whites in Washington.
- Survival rates by race and ethnicity are not available for Washington at this time.
- 23% of lung cancer cases are diagnosed at an early stage among Indigenous Peoples (American Indians/Alaska Natives) in Washington, not significantly different than the rate of 22% among Indigenous Peoples (American Indians/Alaska Natives) nationally, and not significantly different than the rate of 25% among whites in Washington.
- 17% of Indigenous Peoples (American Indians/Alaska Natives) with lung cancer in Washington underwent surgery, not significantly different than the rate of 17% among Indigenous Peoples (American Indians/Alaska Natives) nationally, and not significantly different than the rate of 20% among whites in Washington.
- 28% of Indigenous Peoples (American Indians/Alaska Natives) with lung cancer in Washington did not receive any treatment, not significantly different than the rate of 23% among Indigenous Peoples (American Indians/Alaska Natives) nationally, and not significantly different than the rate of 24% among whites in Washington.
Summary
Despite the early diagnosis rate in Washington falling into the average tier, the state still has a lot of work to do to make sure that more of those at high risk for lung cancer are screened.
Washington has improved access to screening by covering it through its fee-for-service Medicaid program. The Lung Association encourages all states to cover lung cancer screening based on recommended guidelines across all fee-for-service and managed care plans without any financial or administrative barriers in their Medicaid programs.
It is alarming that Washington falls into the below average tier for percent of patients not receiving any treatment. Some patients do refuse treatment, but issues such as fatalism and stigma can prevent eligible patients from accessing treatment that may save or extend their lives. All patients should work with their doctors to establish a treatment plan and goals.